The European Centre for Disease Prevention and Control (ECDC) and European Medicine Agency (EMA) COVID-19 task force today announced they have concluded that it is too early to consider using the fourth dose of mRNA COVID-19 vaccines in the general population.
However, both agencies agreed that a 4th dose (or second booster) of Comirnaty and Spikevax can be given to adults 80 years of age and above.
Europe Delays 4th mRNA Vaccinations
Certain Canadian Oysters Contaminated with Vibrio vulnificus
The U.S. Food and Drug Administration (FDA) recently announced a Public Health Alert advising consumers and retailers to avoid potentially contaminated raw oysters from British Columbia, Canada.
On April 4, 2022, the FDA confirmed that the agency is working with federal, state, and local officials and Canadian public health authorities regarding potential norovirus outbreaks.
Certain Canadian Oysters Contaminated with Vibrio
The U.S. Food and Drug Administration (FDA) recently announced a Public Health Alert advising consumers and retailers to avoid potentially contaminated raw oysters from British Columbia, Canada.
On April 4, 2022, the FDA confirmed that the agency is working with federal, state, and local officials and Canadian public health authorities regarding potential norovirus outbreaks.
Cardiac Complications Up After SARS-CoV-2 Infection Versus Vaccines
Incidence of cardiac outcomes after mRNA COVID-19 vaccination highest in males aged 12 to 17 years, but risk 1.8 to 5.6 times higher after infection
Most COVID-19 Patients Benefit at Long-Term Acute Care Hospitals
Patients treated for COVID-19 discharged with greater improvements in ambulation distance, assistance needs versus reference patients
Vaccination Offers Extra Protection After SARS-CoV-2 Infection
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination
FDA Panel Meets to Craft Future Vaccine Strategy
No official vote is planned, and no specific vaccine products will be discussed
Biden Makes National Push for ‘Long COVID’ Research
Efforts will include speeding up registrations of 40,000 people both with and without long COVID for a study on the condition